|
Dr. David Houchens and Dr. Gregory Douglas Return to Battelle
Dr. Houchens led Battelles major efforts in developmental cancer therapy for the National Cancer Institute for 14 years. In 1990, he joined Neoprobe Corporation, a biotech firm involved in surgical oncology. He served in various capacities there, including Vice President of Clinical Development, Vice President of Corporate Development, and Vice President of Pre-clinical Studies. He received his bachelor of science in biology from Stetson University and his master’s of science in biology and Ph.D. in microbiology/immunology from The George Washington University. Dr. Houchens may be reached at (614)424-3564, houchensd@battelle.org.
Over his 20-year career, he has pioneered the development and application of new highly sensitive analytical tools for the evaluation of bioremediation effectiveness, and detection of organic compounds in complex matrices. As a member of the Exxon Valdez Oil spill damage assessment team, he was Principal Investigator of the Exxon Subtidal Point Source Study to evaluate the sources of hydrocarbon contamination in Prince William Sound. Dr. Douglas received his Ph.D. and M.S. degrees in chemical oceanography from the University of Rhode Islands Graduate School of Oceanography, and his B.S. degree in chemical oceanography from the Florida Institute of Technology. |
| Battelle Home Page | Spring 2001 Issue Home Page | ![]() |